Investors
.jpeg?token=78e5ec25479b88c4741ee3ce677801bf)
Peptinovo Biopharma, LLC was founded to create a novel, low-cost targeted nanoparticle formulation that makes chemo drugs safer and more effective. The company has completed in vivo concept verification and initiating IND-enabling studies. Founders have supported the company investment to date.
Financial Projection
The company is seeking outside investment as well as strategic partnerships. We are currently raising $8-10M. Funds will be used for Phase 1 human trials and discovery on future compounds. The company is also seeking non-dilutive NIH SBIR grants, plus a partnership and grants with leading cancer foundations and internal NIH/NCI faculty.
Intellectual Property: Foundational patent was issued in January 2020 and additional provisional have been filed. Broad PCT coverage and broad-based US filing.